ArticleThe journal of pathology. Clinical research2025

Authors' reply: Re: Yang et al. The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK/ERK mutations and clonal evolution.

Dominik Nann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.